The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study
Open accessAbstract
BACKGROUND Most issues concerning pharmacotherapy of pulmonary sarcoidosis have not been resolved in clinical trials. The objective was to survey sarcoidosis experts concerning the treatment of pulmonary sarcoidosis and attempt to reach a consensus by these experts using a Delphi method. METHODS A 6-item questionnaire was developed. Experts were identified at the Diffuse Lung Disease Network at the annual CHEST meeting in October 2008. Three rounds of questionnaires were presented to the experts. Respondent feedback and supporting literature was incorporated into the questionnaires of subsequent rounds. RESULTS Experts reached a consensus concerning the following issues: (a) corticosteroids are the initial therapy of choice; (b) initial use of inhaled corticosteroids are not recommended; (c) methotrexate was the preferred second-line drug; (d) 40mg of daily prednisone equivalent was the maximum dose recommended for the treatment of acute pulmonary sarcoidosis; (e) tapering to 10mg of daily prednisone equivalent for chronic pulmonary sarcoidosis was considered a successful taper. The experts could not resolve the following issues: (a) the initial corticosteroid dose for the treatment of acute pulmonary sarcoidosis; (b) the decision and timing of corticosteroid therapy in a patient with mild, Stage 2 pulmonary sarcoidosis. CONCLUSIONS This Delphi study revealed that sarcoidosis experts reached a consensus concerning several aspects of the treatment of pulmonary sarcoidosis; these could be considered as appropriate approaches to therapy. Other issues concerning the therapy of pulmonary sarcoidosis remain unresolved by experts, and are areas where further clinical research could be directed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research guidelines for the Delphi survey technique
Hasson, F. (2000) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2000.01567.x · Cited by 5,951
Cited by
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60680-7 · Cited by 1,087
Sarcoidosis in America. Analysis Based on Health Care Use
Baughman, R. P., Field, S., Costabel, U., Crystal, R. G., Culver, D. A., Drent, M., Judson, M. A., & Wolff, G. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201511-760oc · Cited by 421
Self-citationSarcoidosis: Clinical Presentation, Immunopathogenesis, and Therapeutics
Iannuzzi, M. C. (2011) · JAMA · doi:10.1001/jama.2011.10 · Cited by 338
Koźmiński, P., Halik, P. K., Chesori, R., & Gniazdowska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103483 · Cited by 326
Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis
Vorselaars, A. D. M., Wuyts, W. A., Vorselaars, V. M. M., Zanen, P., Deneer, V. H. M., Veltkamp, M., Thomeer, M., van Moorsel, C. H. M., & Grutters, J. C. (2013) · Chest · doi:10.1378/chest.12-1728 · Cited by 282
Metadata
- Authors
- Schutt, A. C., Bullington, W. M., & Judson, M. A.
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 104
- Issue
- 5
- Pages
- 717-723
- ISSN
- 0954-6111 (ISSN-L)
- OpenAlex
- W1990499105
- Cited by
- 206
- References
- 1
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study. https://app.cochat.ai/papers/10.1016/j.rmed.2009.12.009
- The paper
- Schutt, A. C., Bullington, W. M., & Judson, M. A. (2010). Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study. Respiratory Medicine. https://doi.org/10.1016/j.rmed.2009.12.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.